How effective is Sprintec for Menstrual Periods - Heavy, Prolonged, Or Irregular? (a real world drug study)
Summary:
Overall ratings: 3.7/5 Long term ratings: 0/5
This is a phase IV clinical study of how effective Sprintec (ethinyl estradiol; norgestimate) is for Menstrual periods - heavy, prolonged, or irregular and for what kind of people. The study is created by eHealthMe from 6 Sprintec users and is updated continuously.
What is Sprintec?
Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.
What is Menstrual periods - heavy, prolonged, or irregular?
Menstrual periods - heavy, prolonged, or irregular (long menstrual cycle with more bleeding) is found to be associated with 9 conditions by eHealthMe. Check the latest studies of Menstrual periods - heavy, prolonged, or irregular.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
6 people are studied for taking Sprintec in Menstrual periods - heavy, prolonged, or irregular
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Sprintec effectiveness for Menstrual periods - heavy, prolonged, or irregular (number of people):
Overall:
- not at all: 0
- somewhat: 1
- moderate: 1
- high: 3
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 0
- very high: 0
Gender of people who take Sprintec for Menstrual periods - heavy, prolonged, or irregular *:
- female: 100 %
- male: 0.0 %
Age of people who take Sprintec for Menstrual periods - heavy, prolonged, or irregular *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 33.33 %
- 20-29: 33.33 %
- 30-39: 33.33 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Sprintec more effective for Menstrual Periods - Heavy, Prolonged, Or Irregular?
Gender of people who take Sprintec for Menstrual periods - heavy, prolonged, or irregular *:
- female: 100 %
- male: 0.0 %
Age of people who take Sprintec for Menstrual periods - heavy, prolonged, or irregular *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 50 %
- 20-29: 25 %
- 30-39: 25 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Sprintec?
- You can start a phase IV clinical trial to monitor Sprintec safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Sprintec (4,397 reports)
Treatments, associated drugs and conditions:
- Menstrual periods - heavy, prolonged, or irregular (432 reports)
How the study uses the data?
The study is based on ethinyl estradiol; norgestimate (the active ingredients of Sprintec) and Sprintec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cyanocobalamin and Praluent - 11 seconds ago
- Could Fluorouracil cause Oropharyngeal Pain? - 12 seconds ago
- Could Erelzi cause Fibromyalgia? - 13 seconds ago
- Could Novolin N cause Nasopharyngitis? - 16 seconds ago
- Could Zoloft cause Aggression? - 19 seconds ago
- Could Asacol cause Respiratory Disorder? - 20 seconds ago
- Could Metaglip cause Hypoglycemia? - 24 seconds ago
- Could Asa cause Retinal Detachment? - 31 seconds ago
- Could Norvasc cause Ataxia Aggravated? - 33 seconds ago
- Could Norvasc cause Hypocoagulable State? - 38 seconds ago